Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 193 entries
Sorted by: Best Match Show Resources per page
[On the occasion of Swen Malte John's 60th birthday].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete

Frosch PJ, Skudlik C, Schön MP.
PMID: 28424836
Hautarzt. 2017 May;68(5):424-426. doi: 10.1007/s00105-017-3987-3.

No abstract available.

Cite
Frosch PJ, Skudlik C, Schön MP. Swen Malte John zum 60. Geburtstag. [On the occasion of Swen Malte John's 60th birthday]. Hautarzt. 2017;68(5):424-426doi: 10.1007/s00105-017-3987-3.
Frosch, P. J., Skudlik, C., & Schön, M. P. (2017). Swen Malte John zum 60. Geburtstag. [On the occasion of Swen Malte John's 60th birthday]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 68(5), 424-426. https://doi.org/10.1007/s00105-017-3987-3
Frosch, P J, et al. "Swen Malte John zum 60. Geburtstag." [On the occasion of Swen Malte John's 60th birthday]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete vol. 68,5 (2017): 424-426. doi: https://doi.org/10.1007/s00105-017-3987-3
Frosch PJ, Skudlik C, Schön MP. Swen Malte John zum 60. Geburtstag. [On the occasion of Swen Malte John's 60th birthday]. Hautarzt. 2017 May;68(5):424-426. doi: 10.1007/s00105-017-3987-3. German. PMID: 28424836.
Copy Download .nbib Format: NLM
Illegitimate tasks as a source of work stress.

Work and stress

Semmer NK, Jacobshagen N, Meier LL, Elfering A, Beehr TA, Kälin W, Tschan F.
PMID: 25892839
Work Stress. 2015 Jan 02;29(1):32-56. doi: 10.1080/02678373.2014.1003996. Epub 2015 Mar 02.

Illegitimate tasks represent a task-level stressor derived from role and justice theories within the framework of "Stress-as-Offense-to-Self" (SOS; Semmer, Jacobshagen, Meier, & Elfering, 2007). Tasks are illegitimate if they violate norms about what an employee can properly be expected...

Cite
Semmer NK, Jacobshagen N, Meier LL, et al. Illegitimate tasks as a source of work stress. Work Stress. 2015;29(1):32-56doi: 10.1080/02678373.2014.1003996.
Semmer, N. K., Jacobshagen, N., Meier, L. L., Elfering, A., Beehr, T. A., Kälin, W., & Tschan, F. (2015). Illegitimate tasks as a source of work stress. Work and stress, 29(1), 32-56. https://doi.org/10.1080/02678373.2014.1003996
Semmer, Norbert K, et al. "Illegitimate tasks as a source of work stress." Work and stress vol. 29,1 (2015): 32-56. doi: https://doi.org/10.1080/02678373.2014.1003996
Semmer NK, Jacobshagen N, Meier LL, Elfering A, Beehr TA, Kälin W, Tschan F. Illegitimate tasks as a source of work stress. Work Stress. 2015 Jan 02;29(1):32-56. doi: 10.1080/02678373.2014.1003996. Epub 2015 Mar 02. PMID: 25892839; PMCID: PMC4396521.
Copy Download .nbib Format: NLM
BIOPHYSICAL STIMULATION FOR NONUNIONS.

Journal of biological regulators and homeostatic agents

Della Bella E, Tschon M, Stagni C, Dallari D, Fini M.
PMID: 26652488
J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):25-38.

Nonunions account for 5-10% on the total number of fractures. Biophysical stimulation is a non-surgical, conservative, frequently used therapy in nonunions and a greater efficacy has been demonstrated for pulsed electromagnetic fields (PEMF). The mechanisms of action of PEMF...

Cite
Della Bella E, Tschon M, Stagni C, et al. BIOPHYSICAL STIMULATION FOR NONUNIONS. J Biol Regul Homeost Agents. 2015;29(4):25-38
Della Bella, E., Tschon, M., Stagni, C., Dallari, D., & Fini, M. (2015). BIOPHYSICAL STIMULATION FOR NONUNIONS. Journal of biological regulators and homeostatic agents, 29(4), 25-38.
Della Bella, E, et al. "BIOPHYSICAL STIMULATION FOR NONUNIONS." Journal of biological regulators and homeostatic agents vol. 29,4 (2015): 25-38.
Della Bella E, Tschon M, Stagni C, Dallari D, Fini M. BIOPHYSICAL STIMULATION FOR NONUNIONS. J Biol Regul Homeost Agents. 2015 Oct-Dec;29(4):25-38. PMID: 26652488.
Copy Download .nbib Format: NLM
Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells.

Leukemia research reports

Federzoni EA, Gloor S, Jin J, Shan-Krauer D, Fey MF, Torbett BE, Tschan MP.
PMID: 25984443
Leuk Res Rep. 2015 Apr 23;4(1):32-5. doi: 10.1016/j.lrr.2015.04.002. eCollection 2015.

In an mRNA profiling screen performed to unveil novel mechanisms of leukemogenesis, we found that the sentrin-specific protease 5 (SENP5) was significantly repressed in clinical acute myeloid leukemia when compared to healthy neutrophil samples. SENP5 is an enzyme that...

Cite
Federzoni EA, Gloor S, Jin J, et al. Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells. Leuk Res Rep. 2015;4(1):32-5doi: 10.1016/j.lrr.2015.04.002.
Federzoni, E. A., Gloor, S., Jin, J., Shan-Krauer, D., Fey, M. F., Torbett, B. E., & Tschan, M. P. (2015). Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells. Leukemia research reports, 4(1), 32-5. https://doi.org/10.1016/j.lrr.2015.04.002
Federzoni, Elena A, et al. "Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells." Leukemia research reports vol. 4,1 (2015): 32-5. doi: https://doi.org/10.1016/j.lrr.2015.04.002
Federzoni EA, Gloor S, Jin J, Shan-Krauer D, Fey MF, Torbett BE, Tschan MP. Linking the SUMO protease SENP5 to neutrophil differentiation of AML cells. Leuk Res Rep. 2015 Apr 23;4(1):32-5. doi: 10.1016/j.lrr.2015.04.002. eCollection 2015. PMID: 25984443; PMCID: PMC4431638.
Copy Download .nbib Format: NLM
Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells.

Molecular & cellular oncology

Ségal-Bendirdjian E, Tschan MP, Reiffers J, Djavaheri-Mergny M.
PMID: 27308379
Mol Cell Oncol. 2014 Dec 31;1(4):e970066. doi: 10.4161/23723548.2014.970066. eCollection 2014.

p62 regulates key signaling pathways including those that control cell death and autophagy. Recently, we reported that p62 is upregulated during all-trans retinoic acid (ATRA)-induced terminal differentiation of acute myeloid leukemia (AML) cells. This response reduces levels of ubiquitinated...

Cite
Ségal-Bendirdjian E, Tschan MP, Reiffers J, et al. Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells. Mol Cell Oncol. 2014;1(4):e970066doi: 10.4161/23723548.2014.970066.
Ségal-Bendirdjian, E., Tschan, M. P., Reiffers, J., & Djavaheri-Mergny, M. (2014). Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells. Molecular & cellular oncology, 1(4), e970066. https://doi.org/10.4161/23723548.2014.970066
Ségal-Bendirdjian, Evelyne, et al. "Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells." Molecular & cellular oncology vol. 1,4 (2014): e970066. doi: https://doi.org/10.4161/23723548.2014.970066
Ségal-Bendirdjian E, Tschan MP, Reiffers J, Djavaheri-Mergny M. Pro-survival role of p62 during granulocytic differentiation of acute myeloid leukemia cells. Mol Cell Oncol. 2014 Dec 31;1(4):e970066. doi: 10.4161/23723548.2014.970066. eCollection 2014. PMID: 27308379; PMCID: PMC4905221.
Copy Download .nbib Format: NLM
Nondestructive room-temperature adsorption of 2,4,6-tri(2'-thienyl)-1,3,5-triazine on a Si-B interface: high-resolution STM imaging and molecular modeling.

Physical review letters

Makoudi Y, Palmino F, Duverger E, Arab M, Chérioux F, Ramseyer C, Therrien B, Tschan MJ, Süss-Fink G.
PMID: 18352579
Phys Rev Lett. 2008 Feb 22;100(7):076405. doi: 10.1103/PhysRevLett.100.076405. Epub 2008 Feb 22.

Organic nanostructures on semiconductors are currently investigated but the surfaces are known to interact strongly with molecules. To reduce the molecule-surface interaction, we used the Si(111)-B square root 3 x square root 3R30 degrees . Deposition of isolated 2,4,6-tri(2'-thienyl)-1,3,5-triazine,...

Cite
Makoudi Y, Palmino F, Duverger E, et al. Nondestructive room-temperature adsorption of 2,4,6-tri(2'-thienyl)-1,3,5-triazine on a Si-B interface: high-resolution STM imaging and molecular modeling. Phys Rev Lett. 2008;100(7):076405doi: 10.1103/PhysRevLett.100.076405.
Makoudi, Y., Palmino, F., Duverger, E., Arab, M., Chérioux, F., Ramseyer, C., Therrien, B., Tschan, M. J., & Süss-Fink, G. (2008). Nondestructive room-temperature adsorption of 2,4,6-tri(2'-thienyl)-1,3,5-triazine on a Si-B interface: high-resolution STM imaging and molecular modeling. Physical review letters, 100(7), 076405. https://doi.org/10.1103/PhysRevLett.100.076405
Makoudi, Y, et al. "Nondestructive room-temperature adsorption of 2,4,6-tri(2'-thienyl)-1,3,5-triazine on a Si-B interface: high-resolution STM imaging and molecular modeling." Physical review letters vol. 100,7 (2008): 076405. doi: https://doi.org/10.1103/PhysRevLett.100.076405
Makoudi Y, Palmino F, Duverger E, Arab M, Chérioux F, Ramseyer C, Therrien B, Tschan MJ, Süss-Fink G. Nondestructive room-temperature adsorption of 2,4,6-tri(2'-thienyl)-1,3,5-triazine on a Si-B interface: high-resolution STM imaging and molecular modeling. Phys Rev Lett. 2008 Feb 22;100(7):076405. doi: 10.1103/PhysRevLett.100.076405. Epub 2008 Feb 22. PMID: 18352579.
Copy Download .nbib Format: NLM
Telomerisation of buta-1,3-diene and methanol: superiority of chromanyl-type phosphines in the Dow process for the industrial production of 1-MOD.

Chemistry (Weinheim an der Bergstrasse, Germany)

Tschan MJ, Launay H, Hagen H, Benet-Buchholz J, van Leeuwen PW.
PMID: 21695740
Chemistry. 2011 Aug 01;17(32):8922-8. doi: 10.1002/chem.201100684. Epub 2011 Jun 21.

Butadiene and methanol were telomerised in the presence of palladium catalysts with ligands containing 8-diphenylphosphinochromane-like substituents at phosphorus. MonoXantphos and monoSPANphos afforded the most active, stable and selective catalysts known to date under commercially relevant production conditions for 1-methoxyocta-2,7-diene,...

Cite
Tschan MJ, Launay H, Hagen H, et al. Telomerisation of buta-1,3-diene and methanol: superiority of chromanyl-type phosphines in the Dow process for the industrial production of 1-MOD. Chemistry. 2011;17(32):8922-8doi: 10.1002/chem.201100684.
Tschan, M. J., Launay, H., Hagen, H., Benet-Buchholz, J., & van Leeuwen, P. W. (2011). Telomerisation of buta-1,3-diene and methanol: superiority of chromanyl-type phosphines in the Dow process for the industrial production of 1-MOD. Chemistry (Weinheim an der Bergstrasse, Germany), 17(32), 8922-8. https://doi.org/10.1002/chem.201100684
Tschan, Mathieu J-L, et al. "Telomerisation of buta-1,3-diene and methanol: superiority of chromanyl-type phosphines in the Dow process for the industrial production of 1-MOD." Chemistry (Weinheim an der Bergstrasse, Germany) vol. 17,32 (2011): 8922-8. doi: https://doi.org/10.1002/chem.201100684
Tschan MJ, Launay H, Hagen H, Benet-Buchholz J, van Leeuwen PW. Telomerisation of buta-1,3-diene and methanol: superiority of chromanyl-type phosphines in the Dow process for the industrial production of 1-MOD. Chemistry. 2011 Aug 01;17(32):8922-8. doi: 10.1002/chem.201100684. Epub 2011 Jun 21. PMID: 21695740.
Copy Download .nbib Format: NLM
[125 years -- and still going strong].

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Kaufmann R, Enk A, Schön MP, Goerdt S.
PMID: 24393308
J Dtsch Dermatol Ges. 2014 Jan;12(1):1-2. doi: 10.1111/ddg.12276.

No abstract available.

Cite
Kaufmann R, Enk A, Schön MP, et al. 125 Jahre - und kein bisschen leise. [125 years -- and still going strong]. J Dtsch Dermatol Ges. 2014;12(1):1-2doi: 10.1111/ddg.12276.
Kaufmann, R., Enk, A., Schön, M. P., & Goerdt, S. (2014). 125 Jahre - und kein bisschen leise. [125 years -- and still going strong]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 12(1), 1-2. https://doi.org/10.1111/ddg.12276
Kaufmann, Roland, et al. "125 Jahre - und kein bisschen leise." [125 years -- and still going strong]. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 12,1 (2014): 1-2. doi: https://doi.org/10.1111/ddg.12276
Kaufmann R, Enk A, Schön MP, Goerdt S. 125 Jahre - und kein bisschen leise. [125 years -- and still going strong]. J Dtsch Dermatol Ges. 2014 Jan;12(1):1-2. doi: 10.1111/ddg.12276. German. PMID: 24393308.
Copy Download .nbib Format: NLM
Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase.

JIMD reports

Tchan MC, Devine KT, Sillence DO.
PMID: 23430829
JIMD Rep. 2011;1:57-64. doi: 10.1007/8904_2011_17. Epub 2011 Jun 22.

Mucopolysaccharidosis type II (MPS II - Hunter syndrome) is a rare X-linked recessive disease of lysosomal glycosaminoglycan metabolism leading to a systemic storage disorder. We report three adult brothers (aged 46-52 years) with attenuated Hunter syndrome after 12 months...

Cite
Tchan MC, Devine KT, Sillence DO. Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase. JIMD Rep. 2011;1:57-64doi: 10.1007/8904_2011_17.
Tchan, M. C., Devine, K. T., & Sillence, D. O. (2011). Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase. JIMD reports, 157-64. https://doi.org/10.1007/8904_2011_17
Tchan, Michel C, et al. "Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase." JIMD reports vol. 1 (2011): 57-64. doi: https://doi.org/10.1007/8904_2011_17
Tchan MC, Devine KT, Sillence DO. Three Adult Siblings with Mucopolysaccharidosis Type II (Hunter Syndrome): A Report on Clinical Heterogeneity and 12 Months of Therapy with Idursulfase. JIMD Rep. 2011;1:57-64. doi: 10.1007/8904_2011_17. Epub 2011 Jun 22. PMID: 23430829; PMCID: PMC3509811.
Copy Download .nbib Format: NLM
The management of pregnancy in maple syrup urine disease: experience with two patients.

JIMD reports

Tchan M, Westbrook M, Wilcox G, Cutler R, Smith N, Penman R, Strauss BJ, Wilcken B.
PMID: 23430812
JIMD Rep. 2013;10:113-7. doi: 10.1007/8904_2013_212. Epub 2013 Feb 14.

We describe the management and outcomes of pregnancy in two women affected with Maple syrup urine disease (MSUD). Both patients had classical disease diagnosed in the newborn period and were managed with low-protein diets and supplements, although compliance was...

Cite
Tchan M, Westbrook M, Wilcox G, et al. The management of pregnancy in maple syrup urine disease: experience with two patients. JIMD Rep. 2013;10:113-7doi: 10.1007/8904_2013_212.
Tchan, M., Westbrook, M., Wilcox, G., Cutler, R., Smith, N., Penman, R., Strauss, B. J., & Wilcken, B. (2013). The management of pregnancy in maple syrup urine disease: experience with two patients. JIMD reports, 10113-7. https://doi.org/10.1007/8904_2013_212
Tchan, Michel, et al. "The management of pregnancy in maple syrup urine disease: experience with two patients." JIMD reports vol. 10 (2013): 113-7. doi: https://doi.org/10.1007/8904_2013_212
Tchan M, Westbrook M, Wilcox G, Cutler R, Smith N, Penman R, Strauss BJ, Wilcken B. The management of pregnancy in maple syrup urine disease: experience with two patients. JIMD Rep. 2013;10:113-7. doi: 10.1007/8904_2013_212. Epub 2013 Feb 14. PMID: 23430812; PMCID: PMC3755568.
Copy Download .nbib Format: NLM
Leucaemia cutis bei einem Patienten mit chronischer myelomonozytärer Leukämie.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Claßen A, Kitz J, Perske C, Overbeck T, Bertsch HP, Schön MP, Lippert U.
PMID: 29314680
J Dtsch Dermatol Ges. 2018 Jan;16(1):82-84. doi: 10.1111/ddg.13398_g.

No abstract available.

Cite
Claßen A, Kitz J, Perske C, et al. Leucaemia cutis bei einem Patienten mit chronischer myelomonozytärer Leukämie. J Dtsch Dermatol Ges. 2018;16(1):82-84doi: 10.1111/ddg.13398_g.
Claßen, A., Kitz, J., Perske, C., Overbeck, T., Bertsch, H. P., Schön, M. P., & Lippert, U. (2018). Leucaemia cutis bei einem Patienten mit chronischer myelomonozytärer Leukämie. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 16(1), 82-84. https://doi.org/10.1111/ddg.13398_g
Claßen, Anna, et al. "Leucaemia cutis bei einem Patienten mit chronischer myelomonozytärer Leukämie." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 16,1 (2018): 82-84. doi: https://doi.org/10.1111/ddg.13398_g
Claßen A, Kitz J, Perske C, Overbeck T, Bertsch HP, Schön MP, Lippert U. Leucaemia cutis bei einem Patienten mit chronischer myelomonozytärer Leukämie. J Dtsch Dermatol Ges. 2018 Jan;16(1):82-84. doi: 10.1111/ddg.13398_g. PMID: 29314680.
Copy Download .nbib Format: NLM
Biosimilars in der Dermatologie - Theorie wird Realität.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG

Gerdes S, Mrowietz U, Augustin M, von Kiedrowski R, Enk A, Strömer K, Schön MP, Radtke MA.
PMID: 29418106
J Dtsch Dermatol Ges. 2018 Feb;16(2):150-162. doi: 10.1111/ddg.13410_g.

Biosimilars sind biologische Medikamente, bei denen es sich um Nachbildungen eines spezifischen Referenzprodukts handelt. Biosimilars der Tumornekrosefaktor-alpha-Inhibitoren Infliximab und Etanercept sind bereits zugelassen und stehen für dermatologische Indikationen zur Verfügung. Die Aufsichtsbehörden verlangen eine eingehende Analyse der physikochemischen und...

Cite
Gerdes S, Mrowietz U, Augustin M, et al. Biosimilars in der Dermatologie - Theorie wird Realität. J Dtsch Dermatol Ges. 2018;16(2):150-162doi: 10.1111/ddg.13410_g.
Gerdes, S., Mrowietz, U., Augustin, M., von Kiedrowski, R., Enk, A., Strömer, K., Schön, M. P., & Radtke, M. A. (2018). Biosimilars in der Dermatologie - Theorie wird Realität. Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 16(2), 150-162. https://doi.org/10.1111/ddg.13410_g
Gerdes, Sascha, et al. "Biosimilars in der Dermatologie - Theorie wird Realität." Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG vol. 16,2 (2018): 150-162. doi: https://doi.org/10.1111/ddg.13410_g
Gerdes S, Mrowietz U, Augustin M, von Kiedrowski R, Enk A, Strömer K, Schön MP, Radtke MA. Biosimilars in der Dermatologie - Theorie wird Realität. J Dtsch Dermatol Ges. 2018 Feb;16(2):150-162. doi: 10.1111/ddg.13410_g. PMID: 29418106.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 193 entries